SCM

Stonepine Capital Management Portfolio holdings

AUM $126M
1-Year Est. Return 70.12%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+70.12%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$123M
AUM Growth
+$21.5M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
77
New
Increased
Reduced
Closed

Top Buys

1
+$9.75M
2
+$4.83M
3
+$3.92M
4
XFOR icon
X4 Pharmaceuticals
XFOR
+$2.72M
5
ABEO icon
Abeona Therapeutics
ABEO
+$2.57M

Top Sells

1
+$5.23M
2
+$3.09M
3
+$2.52M
4
ENTA icon
Enanta Pharmaceuticals
ENTA
+$2.39M
5
ANIK icon
Anika Therapeutics
ANIK
+$2.02M

Sector Composition

1 Healthcare 99.76%
2 Financials 0.24%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YMAB
76
DELISTED
Y-mAbs Therapeutics
YMAB
– –
-285,300
CLYM
77
Climb Bio
CLYM
$488M
– –
-116,147
1 2 3
4